(MedPage Today) — Biomarkers for cancer — often reported with great publicity — routinely fail to be of clinical use, a Canadian researcher said.
Posted on August 14, 2010 | Filed under Urology News | Permalink
(MedPage Today) — The maker of the prostate cancer immunotherapy sipuleucel-T (Provenge) has exaggerated the therapy’s efficacy and played down its risks in some marketing materials, the FDA charged.
Posted on August 14, 2010 | Filed under Urology News | Permalink
(MedPage Today) — Men taking a dietary supplement marketed as a sexual function aid had a significant increase in cardiac QTc interval that persisted for five hours after a single dose, a small study of healthy volunteers showed.
Posted on August 12, 2010 | Filed under Urology News | Permalink
(MedPage Today) — A questionnaire for men with prostate cancer that evaluates comorbidities may help in clinical decision-making about treatment by estimating their likelihood of dying from other conditions, researchers found.
Posted on August 12, 2010 | Filed under Urology News | Permalink
(MedPage Today) — Physicians continue to shy away from prescribing finasteride to prevent prostate cancer, despite evidence from a large clinical trial showing that the drug significantly reduced the risk, a survey showed.
Posted on August 12, 2010 | Filed under Urology News | Permalink
(MedPage Today) — Bone scans might help identify men at high risk for aggressive prostate tumors as they age, researchers said.
Posted on July 30, 2010 | Filed under Urology News | Permalink
Many men being treated aggressively for low-grade prostate cancer (MedPage Today) — particularly if it was detected during prostate-specific antigen screening — are unlikely to benefit from the intervention, a new study suggests.
Posted on July 28, 2010 | Filed under Urology News | Permalink
Many men being treated aggressively for low-grade prostate cancer (MedPage Today) — particularly if it was detected during prostate-specific antigen screening — are unlikely to benefit from the intervention, a new study suggests.
Posted on July 27, 2010 | Filed under Urology News | Permalink
Gene therapy appears to have long-term success for treating X-linked severe combined immunodeficiency disease (SCID) (MedPage Today) — but recipients are at risk for acute leukemia, according to a small study from France.
Posted on July 21, 2010 | Filed under Urology News | Permalink
People exposed to paint on the job (MedPage Today) — including painters plasterers, artists, decorators, and other workers — appear to have an increased risk of bladder cancer, a meta-analysis showed.
Posted on July 19, 2010 | Filed under Urology News | Permalink
A major retrospective study showed that men prescribed erectile dysfunction (ED) drugs such as sildenafil (Viagra) also had markedly higher rates of sexually transmitted diseases (MedPage Today) — though the association could have more to do with behavior than ED drug use.
Posted on July 7, 2010 | Filed under Urology News | Permalink
WASHINGTON (MedPage Today) — The Centers for Medicare and Medicaid Services announced it has started the process of deciding whether to cover the costly prostate cancer immunotherapeutic agent sipuleucel-T (Provenge).
Posted on July 2, 2010 | Filed under Urology News | Permalink
Applying topical testosterone appears to raise the risk of cardiovascular events including myocardial infarction, atrial fibrillation, and stroke in older men with limited mobility, a study has found.
Posted on June 30, 2010 | Filed under Urology News | Permalink
Screening based on prostate-specific antigen (PSA) dramatically reduced mortality from prostate cancer in a large 14-year randomized trial in Swedish men, researchers said.
Posted on June 30, 2010 | Filed under Urology News | Permalink
Among men who underwent radical prostatectomy, biochemical recurrence (MedPage Today) — a spike in prostate specific antigen (PSA) over a critical threshold — was less likely in men on statin therapy, a retrospective study showed.
Posted on June 29, 2010 | Filed under Urology News | Permalink
LAS VEGAS (MedPage Today) — Sexual function improved in almost 70% of obese women who underwent bariatric surgery, according to data from a small prospective cohort study.
Posted on June 26, 2010 | Filed under Urology News | Permalink
Exposure to the long-banned organochloride insecticide chlordecone may be associated with a greater chance of developing prostate cancer, a new case-control study showed.
Posted on June 21, 2010 | Filed under Urology News | Permalink
Jain Abhishek, Goel Apul, Sankhwar S N
Indian Journal of Urology 2010 26(1):153-155
Posted on June 19, 2010 | Filed under Urology News | Permalink
Indian Journal of Urology 2010 26(1):156-156
Posted on June 19, 2010 | Filed under Urology News | Permalink
Singh Bhupendra P, Goel Apul, Gupta Ankush
Indian Journal of Urology 2010 26(1):149-150
Posted on June 19, 2010 | Filed under Urology News | Permalink
Singh Bhupendra P, Choubey Vimal K, Pandey Rahul
Indian Journal of Urology 2010 26(1):150-152
Posted on June 19, 2010 | Filed under Urology News | Permalink
Nirmal T J, Kumar S
Indian Journal of Urology 2010 26(1):152-153
Posted on June 19, 2010 | Filed under Urology News | Permalink
Veeramani Muthu, Vyas Jigish, Sabnis Ravindra, Desai Mahesh
Indian Journal of Urology 2010 26(1):145-147
End-stage renal disease is a significant health problem. The primary use of the autogenous arteriovenous access is recommended by NKF-DOQI (National Kidney Foundation-Dialysis Outcomes Quality Initiative) guidelines. Though basilic vein transposition is well established in multiple failed fistulae's and obese patients, it requires large incision and morbidities like edema and infection. To avoid such compilations we, at our institution, adopted a small incision technique using two small 3-4 cm incisions. This method is inspired by videoendoscopic minimally invasive method used to dissect the basilic vein, thus avoiding extensive dissection and related morbidities.
Posted on June 19, 2010 | Filed under Urology News | Permalink
Nirmal T J, Kekre Nitin S
Indian Journal of Urology 2010 26(1):148-149
Posted on June 19, 2010 | Filed under Urology News | Permalink
Mukha Rajiv Paul, Kumar Santosh, Kekre N S
Indian Journal of Urology 2010 26(1):133-138
Prostate cancer has now become one of the leading types of cancer in urban India. It is now the third most common cancer in Delhi. As we advance in health care with the resultant increase in longevity, we will be seeing more of advanced carcinoma prostate. Since the early 1980.s, there have been many trials on MAB. However, the question remains whether these agents actually make a difference? The role of MAB is probably limited to the prevention of the ß are reaction in patients on LHRH agonists. The non steroidal antiandrogens have a marginal benefit of increased overall survival by approximately 3% to 5% at 5 ve years. There may be a role for MAB in patients with metastatic carcinoma of prostate, low volume metastases, patients with M 1 disease with absence of metastases in the skull, ribs, long bones, and soft tissues excluding lymph nodes.
Posted on June 19, 2010 | Filed under Urology News | Permalink
Copyright @ 2001 and Beyond Fertility Portal: Fertility and Infertility Research News
Web Design By Dynamic Creator | Web Hosting by Trade Web Hosting